Ultragenyx Pharmaceutical annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Ultragenyx Pharmaceutical Debt-to-Assets Ratio Growth & History (RARE)
Ultragenyx Pharmaceutical's debt-to-assets ratio was 0.02 for fiscal 2025.
View full Ultragenyx Pharmaceutical company overviewUltragenyx Pharmaceutical annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.02 | −0.00 | −12.45% |
| 2024 | 2024-12-31 | 0.03 | −0.00 | −7.30% |
| 2023 | 2023-12-31 | 0.03 | 0.01 | +41.63% |
| 2022 | 2022-12-31 | 0.02 | −0.01 | −25.85% |
| 2021 | 2021-12-31 | 0.03 | 0.00 | +0.58% |
| 2020 | 2020-12-31 | 0.03 | −0.01 | −15.87% |
| 2019 | 2019-12-31 | 0.03 | — | — |
Ultragenyx Pharmaceutical quarterly debt-to-assets ratio
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.02 | −0.00 | −12.45% |
| Q3 2025 | 2025-09-30 | 0.03 | — | — |
| Q2 2025 | 2025-06-30 | 0.03 | — | — |
| Q1 2025 | 2025-03-31 | 0.03 | — | — |
| Q4 2024 | 2024-12-31 | 0.03 | −0.00 | −7.30% |
| Q4 2023 | 2023-12-31 | 0.03 | 0.01 | +41.63% |
| Q4 2022 | 2022-12-31 | 0.02 | −0.01 | −25.85% |
| Q4 2021 | 2021-12-31 | 0.03 | 0.00 | +0.58% |
| Q4 2020 | 2020-12-31 | 0.03 | −0.01 | −15.87% |
| Q3 2020 | 2020-09-30 | 0.04 | −0.04 | −55.76% |
| Q2 2020 | 2020-06-30 | 0.03 | −0.04 | −56.41% |
| Q1 2020 | 2020-03-31 | 0.03 | −0.02 | −32.29% |
| Q4 2019 | 2019-12-31 | 0.03 | — | — |
| Q3 2019 | 2019-09-30 | 0.08 | — | — |
| Q2 2019 | 2019-06-30 | 0.08 | — | — |
| Q1 2019 | 2019-03-31 | 0.05 | — | — |
Ultragenyx Pharmaceutical debt-to-assets ratio trends
Over the last five fiscal years, Ultragenyx Pharmaceutical's debt-to-assets ratio decreased from 0.03 to 0.02, a change of −0.00. The latest reported quarter, Q4 2025, shows 0.02.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ultragenyx Pharmaceutical source filings ↗